Screening for Down syndrome in the second trimester of pregnancy.

Antenatal screening for fetal anomalies has provided women and their partners with information to make reproductive choices based on the risk of serious chromosomal or structural defects since the 1990s. Alternative tests include first-trimester screening (combined ultrasound and maternal serum mark...

Full description

Bibliographic Details
Main Authors: O'Leary, Peter, Maxwell, S., Sinosich, M., DeVoss, K., Fletcher, J., Ranieri, E., Metz, M.
Format: Journal Article
Published: 2016
Online Access:http://hdl.handle.net/20.500.11937/4130
_version_ 1848744428745785344
author O'Leary, Peter
Maxwell, S.
Sinosich, M.
DeVoss, K.
Fletcher, J.
Ranieri, E.
Metz, M.
author_facet O'Leary, Peter
Maxwell, S.
Sinosich, M.
DeVoss, K.
Fletcher, J.
Ranieri, E.
Metz, M.
author_sort O'Leary, Peter
building Curtin Institutional Repository
collection Online Access
description Antenatal screening for fetal anomalies has provided women and their partners with information to make reproductive choices based on the risk of serious chromosomal or structural defects since the 1990s. Alternative tests include first-trimester screening (combined ultrasound and maternal serum markers), second-trimester maternal serum markers and noninvasive cell-free DNA testing. The recent recommendations by the Royal Australian and New Zealand College of Obstetrics and Gynaecology and the Human Genetics Society of Australasia against second-trimester triple testing are based on unsound performance criteria, raise several contestable issues around access and equity and challenge the principles of governments providing affordable options.
first_indexed 2025-11-14T06:01:19Z
format Journal Article
id curtin-20.500.11937-4130
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:01:19Z
publishDate 2016
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-41302017-09-13T14:33:02Z Screening for Down syndrome in the second trimester of pregnancy. O'Leary, Peter Maxwell, S. Sinosich, M. DeVoss, K. Fletcher, J. Ranieri, E. Metz, M. Antenatal screening for fetal anomalies has provided women and their partners with information to make reproductive choices based on the risk of serious chromosomal or structural defects since the 1990s. Alternative tests include first-trimester screening (combined ultrasound and maternal serum markers), second-trimester maternal serum markers and noninvasive cell-free DNA testing. The recent recommendations by the Royal Australian and New Zealand College of Obstetrics and Gynaecology and the Human Genetics Society of Australasia against second-trimester triple testing are based on unsound performance criteria, raise several contestable issues around access and equity and challenge the principles of governments providing affordable options. 2016 Journal Article http://hdl.handle.net/20.500.11937/4130 10.1111/ajo.12411 restricted
spellingShingle O'Leary, Peter
Maxwell, S.
Sinosich, M.
DeVoss, K.
Fletcher, J.
Ranieri, E.
Metz, M.
Screening for Down syndrome in the second trimester of pregnancy.
title Screening for Down syndrome in the second trimester of pregnancy.
title_full Screening for Down syndrome in the second trimester of pregnancy.
title_fullStr Screening for Down syndrome in the second trimester of pregnancy.
title_full_unstemmed Screening for Down syndrome in the second trimester of pregnancy.
title_short Screening for Down syndrome in the second trimester of pregnancy.
title_sort screening for down syndrome in the second trimester of pregnancy.
url http://hdl.handle.net/20.500.11937/4130